Higher folate and vitamin B6 intake years before Parkinson’s diagnosis is linked to reduced mortality risk, but postdiagnosis ...

This study addresses endosomal escape in oligonucleotide therapies and how engineered peptides can enhance intracellular drug delivery efficiency.

The study evaluates how omega-3 delivery architecture influences triglyceride outcomes and omega-3 incorporation in ...

Turmeric and ibuprofen both reduce inflammation and pain, but they work in different ways. Learn how curcumin extract (from ...

Its primary program targets multiple sclerosis (MS), but BioNxt also intends to apply the same proprietary drug delivery platform to develop a treatment for Myasthenia Gravis (MG), a rare autoimmune ...

Bionxt Solutions is accelerating development of its flagship project, moving a Cladribin-based dissolvable film toward human ...

A new study reveals that biochar can create tiny but powerful soil microenvironments that significantly reduce cadmium contamination in crops. The findings offer fresh insight into how this ...

OPKO Health, Inc. (NASDAQ: OPK), through its wholly owned subsidiary, OPKO Biologics (OPKO), and Entera Bio Ltd. (NASDAQ: ENTX) (Entera or the Company), a leader in the development of oral peptide and ...

Scientists at NYU Abu Dhabi have developed an innovative use for nanotechnology in the field of cancer research. Their ...

A new study reveals that biochar can create tiny but powerful soil microenvironments that significantly reduce cadmium contamination in crops. The ...

Bionxt Solutions has reported significant progress in its primary development program, with new preclinical data paving the way for initial human trials. The company is also broadening its strategic ...

Click below for earlier editions: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 ...